Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Comment by Mil_Man54on Nov 04, 2021 12:33pm
78 Views
Post# 34087326

RE:RE:More acquisition in the works?

RE:RE:More acquisition in the works?So Gobbler is saying that anyone who doesn't agree with the pumper posts is a basher shortseller....got it....that makes perfect sense...... Gobbler....what great strides have they made and how is that ship being turned around.....is it the continued dilution od shares....the $2.5M annually and 219936 shares for 6 marketing firms....is it the granting of stock options for the BoD and management for no performance.......you have to be more specific because it's very difficult to steer a sinking ship.....so I've heard....

GreatGabbo wrote:

Couldn't agree more bro, this company is making some serious moves towards success. Anyone who says otherwise is a basher/short seller who wants to see FSD fail. 


It's so obvious that FSD is turning the ship around with Anthony at the helm, I love FSD PHARMA <3

 

DavidRosenberg wrote: I wonder if they will do more acquisitions 

Personally I think LUCID is enough because they can research many molecules over at UHN if needed.

Thats like a one stop shop for everything related to R&D for drugs.

Lucid MS and Lucid Psych for Major Depressive Disorder

 

 



<< Previous
Bullboard Posts
Next >>